The Food and Drug Administration rejected a bid from Elon Musk's human brain chips startup Neuralink to start human trials, according to Reuters.
Share:
More In Science
Botox Turns 30 (But Doesn't Look a Day Over 25)
Pharmaceutical giant Allergan got FDA approval in 1989 to use Botulinum toxin for clinical use, representing a medical breakthrough: the first time microbial bacteria was approved for injection into the human body.
MagniX CEO on First Electric Commercial Flight: 'It's Not Less Emission, It's Zero Emissions'
CEO Roei Ganzarski said the excitement of the moment the first electric-powered commercial flight took off felt like the birth of another child.
Solar Posts Record Gains in U.S. Residential Market
The U.S. residential solar market posted its biggest quarter on record in Q3 2019, according to a report by Wood Mackenzie Power and Renewables.
Climate Activist Greta Thunberg Named Time's 2019 Person of the Year
Greta Thunberg, the Swedish teenage climate activist, is Time's 2019 Person of the Year. The 16-year-old is the youngest person to ever receive the honor
Disney+ Tops Google's Most Searched Trends of 2019
Google's 'Year in Search' report is out, and it shows what we've all been looking for in 2019.
Need 2 Know: The Afghan Papers, Vanna's Turn
These are the headlines you Need 2 Know for Tuesday, December 10, 2019.
Need 2 Know: Impeachment Evidence, Volcano Disaster
These are the headlines you Need 2 Know for Monday, December 9, 2019.
Seattle Startup to Offer New Afterlife Option: Human Composting
Recompose | SEATTLE recently unveiled renderings for what it says will be the world's first site for composting human remains, or what it's calling the first truly "sustainable option for after-death care."
Ford and McDonald's Team Up to Build Coffee Bean-Based Car Parts
The automaker and breakfast purveyor announced a collaboration to create plastic vehicle parts out of coffee bean waste from the roasting process.
